Non‐invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Cancer

• Publication date

  2016-04-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/ijc.29932PMID 26595604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Magnetic Resonance Spectroscopy for Detection of Choline Kinase Inhibition in the Treatment of Brain Tumors

  2015cited by this paper
• Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer Cells

  2014cited by this paper
• A mitochondrial switch promotes tumor metastasis.

  2014cited by this paper
• Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion-weighted MRI, choline spectroscopy and 18F-FLT PET imaging.

  2013cited by this paper
• Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: a rationale for combination with radiation therapy.

  2012cited by this paper
• Targeted-therapy and imaging response: a new paradigm for clinical evaluation?

  2011cited by this paper
• In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients

  2011cited by this paper
• Choline metabolism in malignant transformation

  2011cited by this paper
• Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?

  2010cited by this paper
• Modulation of choline kinase activity in human cancer cells observed by dynamic 31P NMR

  2009cited by this paper
• Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy

  2008cited by this paper
• Diffusion-weighted MRI in the body: applications and challenges in oncology.

  2007cited by this paper
• MRI‐measured water mobility increases in response to chemotherapy via multiple cell‐death mechanisms

  2007cited by this paper
• Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.

  2006cited by this paper
• Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.

  2006cited by this paper
• RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.

  2005cited by this paper
• Tumor Dose Response to the Vascular Disrupting Agent, 5,6-Dimethylxanthenone-4-Acetic Acid, Using In vivo Magnetic Resonance Spectroscopy

  2005cited by this paper
• Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition.

  2005cited by this paper
• High‐resolution magic‐angle‐spinning 1H NMR spectroscopy reveals different responses in choline‐containing metabolites upon gene therapy‐induced programmed cell death in rat brain glioma

  2005cited by this paper
• Structure and function of choline kinase isoforms in mammalian cells.

  2004cited by this paper
• Metabolic response of the CWR22 prostate tumor xenograft after 20 Gy of radiation studied by 1H spectroscopic imaging.

  2003cited by this paper
• Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy

  2002cited by this paper
• Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions.

  2002cited by this paper
• Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer

  2001cited by this paper
• Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.

  1999cited by this paper
• Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells.

  1996cited by this paper
• Choline phosphokinase.

  1953cited by this paper

• Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells

  2022cites this paper
• [99mTc]Tc-DTPA-Bis(cholineethylamine) as an Oncologic Tracer for the Detection of Choline Transporter (ChT) and Choline Kinase (ChK) Expression in Cancer

  2022cites this paper
• Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer

  2022cites this paper
• Proton Magnetic Resonance Spectroscopy at 3.0T in Rabbit With VX2 Liver Cancer: Diagnostic Efficacy and Correlations With Tumor Size

  2022cites this paper
• Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway

  2019cites this paper
• MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K‐AKT‐β‐catenin pathways

  2019cites this paper
• Role of animal research in human malignancies

  2019cites this paper
• Multimodal imaging for tumour characterization from micro‐ to macroscopic level using a newly developed dorsal chamber designed for long‐term follow‐up

  2019cites this paper
• 2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck

  2018cites this paper
• Noninvasive magnetic resonance/photoacoustic imaging for photothermal therapy response monitoring.

  2018cites this paper
• Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas

  2018cites this paper
• Magnetic Resonance Spectroscopy and its Clinical Applications: A Review.

  2017cites this paper
• A two-step strategy to radiolabel choline phospholipids with 99mTc in S180 cell membranes via strain-promoted cyclooctyne-azide cycloaddition reaction.

  2016cites this paper
• Choline Metabolism Alteration: A Focus on Ovarian Cancer

  2016cites this paper
• Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer

  2016cites this paper